Prime Medicine, Inc. (PRME)

NASDAQ: PRME · Real-Time Price · USD

3.640

+0.040 (1.11%)

At close: Dec 19, 2025, 4:00 PM EST

3.680

+0.040 (1.10%)

After-hours: Dec 19, 2025, 7:58 PM EST

Revenue by Product

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2020
Period Ending	Dec '24 Dec 31, 2024	Dec '20 Dec 31, 2020
Genetic Therapies	2.98M	Log In
Genetic Therapies Growth	-42.74%	Log In

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2020
Period Ending	Dec '24 Dec 31, 2024	Dec '20 Dec 31, 2020
United States	2.98M	Log In
United States Growth	-42.74%	Log In